Aptose Net Income From Continuing Ops from 2010 to 2026
| APS Stock | CAD 2.26 0.01 0.44% |
Net Loss | First Reported 2016-12-31 | Previous Quarter -7 M | Current Value -5.1 M | Quarterly Volatility 4.7 M |
Check Aptose Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aptose Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 27.4 K, Selling General Administrative of 6.8 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 2.8 K, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Aptose financial statements analysis is a perfect complement when working with Aptose Biosciences Valuation or Volatility modules.
Aptose | Net Income From Continuing Ops |
Evaluating Aptose Biosciences's Net Income From Continuing Ops across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Aptose Biosciences's fundamental strength.
Latest Aptose Biosciences' Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Aptose Biosciences over the last few years. It is Aptose Biosciences' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aptose Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Aptose Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (25,522,318) | |
| Coefficient Of Variation | (69.13) | |
| Mean Deviation | 13,603,893 | |
| Median | (22,887,000) | |
| Standard Deviation | 17,642,372 | |
| Sample Variance | 311.3T | |
| Range | 54.8M | |
| R-Value | (0.60) | |
| Mean Square Error | 211.4T | |
| R-Squared | 0.36 | |
| Significance | 0.01 | |
| Slope | (2,105,407) | |
| Total Sum of Squares | 4980.1T |
Aptose Net Income From Continuing Ops History
About Aptose Biosciences Financial Statements
Aptose Biosciences investors utilize fundamental indicators, such as Net Income From Continuing Ops, to predict how Aptose Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -22.9 M | -24 M |
Pair Trading with Aptose Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptose Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving against Aptose Stock
| 0.42 | NVDA | NVIDIA CDR | PairCorr |
| 0.42 | NVDA | Nvidia CDR | PairCorr |
| 0.34 | MSFT | Microsoft Corp CDR | PairCorr |
| 0.34 | MSFT | Microsoft CDR | PairCorr |
| 0.31 | AMZN | Amazon CDR | PairCorr |
The ability to find closely correlated positions to Aptose Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptose Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptose Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptose Biosciences to buy it.
The correlation of Aptose Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptose Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptose Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptose Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Aptose Stock
Aptose Biosciences financial ratios help investors to determine whether Aptose Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aptose with respect to the benefits of owning Aptose Biosciences security.